ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

C8H12O8Pb

HCID 9846230
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
12365-56-9
標準SMILES
CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Pb]
InChIKey
JEHCHYAKAXDFKV-UHFFFAOYSA-J
分子式
C8H12O8Pb-4
平均分子量
443 g/mol
単同位体質量
444.02987

概要

Lead tetraacetate is a chemical compound of lead. Lead is a heavy metal and stable element with the symbol Pb and the atomic number 82, existing in metallic, organic, and inorganic forms. It is mainly found in nature as the mineral galena (PbS), cerussite (PbCO3) or anglesite (PbSO4), usually in ore with zinc, silver, or copper. (L21)

名称と識別子

優先名称
C8H12O8Pb
英語名
tris(acetyloxy)plumbyl acetate
分子式
C8H12O8Pb
分子量
443.37608

名称と別名

MFCD00008693C8H12O8PbLeadtetraacetatelead tetra-acetatetriacetoxyplumbyl acetateLead (IV) tetraacetatelead (IV) tetra acetatelead (IV) tetra-acetateSCHEMBL56748C8H12O8Pb-4NVTAREBLATURGT-UHFFFAOYSA-JDTXSID801047756
名称をさらに表示
AKOS025243798FL49177Tetrakis(acetato-kappaO,kappaOa(2))leadSY008932L0021NS00080611Lead(IV) acetate(Stabilized with 5-10% Acetic acid)Lead(IV) acetate(Contains 4-10% Glacial Acetic acid)

データベース識別子

CAS
12365-56-9
PubChem CID
9846230
DTXSID
DTXSID801047756
Nikkaji
J43.169I

物性

構造計算による物性

極性表面積
161 Ų
水素結合供与体数
0
水素結合受容体数
8
回転可能結合数
0
重原子数
17
形式電荷
-4
複雑度
25.5

物理化学的性質

融点
177 · 177-179 °C

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

CSL Reaction Information · 6 件

CSL00100

Lead acetate + PICRIC ACID

Potentially explosive

Explosive

User-Reported

7/8/18

安全と保護具

Minimum Risk LevelChronic Inhalation: 0.05 mg/m3 (L134)

毒性情報

TreatmentLead poisoning is usually treated with chelation therapy using DMSA, EDTA, or dimercaprol. (L21)
Health Effects · 1 件

Lead is a neurotoxin and has been known to cause brain damage and reduced cognitive capacity, especially in children. Lead exposure can result in nephropathy, as well as blood disorders such as high blood pressure and anemia. Lead also exhibits reproductive toxicity and can results in miscarriages and reduced sperm production. (L21)

Exposure RoutesOral (L136) ; inhalation (L136) ; dermal (L136)
Toxicity Summary · 1 件

Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example, lead has been shown to competitively inhibit calcium's binding of calmodulin, interferring with neurotransmitter release. It exhibits similar competitive inhibition at the NMDA receptor and protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. Lead also affects the nervous system by impairing regulation of dopamine synthesis and blocking evoked release of acetylcholine. However, it's main mechanism of action occurs by inhibiting delta-aminolevulinic acid dehydratase, an enzyme vital in the biosynthesis of heme, which is a necesssary cofactor of hemoglobin. (T4, A20, A22, L136)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Lead is absorbed following inhalation, oral, and dermal exposure. It is then distributed mainly to the bones and red blood cells. In the blood lead may be found bound to serum albumin or the metal-binding protein metallothionein. Organic lead is metabolized by cytochrome P-450 enzymes, whereas inorganic lead forms complexes with delta-aminolevulinic acid dehydratase. Lead is excreted mainly in the urine and faeces. (L136)

サプライヤー1 社

杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Signs and Symptoms · 1 件

Symptions of chronic lead poisoning include reduced cognitive abilities, nausea, abdominal pain, irritability, insomnia, metal taste in the mouth, excess lethargy or hyperactivity, chest pain, headache and, in extreme cases, seizures, comas, and death. There are also associated gastrointestinal problems, such as constipation, diarrhea, vomiting, poor appetite, weight loss, which are common in acute poisoning. (A2, L21)

Carcinogen Classification · 1 件

Organic lead compounds are not classifiable as to their carcinogenicity to humans (Group 3). To the extent that organic lead compounds are metabolized in part to ionic lead, they are expected to exert the toxicities associated with inorganic lead (Group 2A, probably carcinogenic to humans). (L135)